Results 101 to 110 of about 259,058 (180)
Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor +4 more
wiley +1 more source
ABSTRACT Sonodynamic therapy (SDT) is an emerging site specific and minimally‐invasive modality for cancer treatment. Its efficacy heavily relies on the accumulation and retention of systemically‐administered sensitizing agents within tumor cells.
Yidong Wang +2 more
wiley +1 more source
ABSTRACT Background No study has specifically addressed the initial supervised experience of novice surgeons using the Hugo RAS system. Methods We retrospectively reviewed patients with prostate cancer receiving robot‐assisted radical prostatectomy (RARP).
Che‐Hsueh Yang +7 more
wiley +1 more source
ABSTRACT Introduction Transgender and gender diverse (TGD) people continue to experience inequities in access to gender‐affirming care, including stigmatisation, delayed treatment and non‐inclusive healthcare encounters. Community pharmacies may represent an accessible setting to support inclusive and affirming care; however, lived experiences of ...
Jessica McCann +5 more
wiley +1 more source
Can a single element help address the multifactorial nature of ALS? Boron‐containing compounds combine responsiveness to reactive oxygen species (ROS), neuroprotective activity, and favorable pharmacological properties, offering a distinctive framework for disease modification in a complex disease like ALS.
Nitesh Sanghai +5 more
wiley +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
We show that emergence of castration‐resistant prostate (CRPC) is associated with significant upregulation of cyclins that positively regulate cyclin‐dependent kinase 2 (CDK2) and concomitant downregulation of CDK4 cyclins. This renders CRPC cells dependent on the high activity of CDK2, and CDK2 inhibitors synergistically sensitize CRPC cells to both ...
Joyeeta Chatterjee +3 more
wiley +1 more source
Androgen receptor signaling in prostate cancer: Genetic and molecular aspects
The prostate is an accessory sex gland of the male reproductive system, which produces alkaline prostatic fluid, capable of ensuring the spermatic viability to fertilize eggs within the female reproductive system.
Fioruci-Fontanelli, B. A. [UNESP] +2 more
core
Androgen receptor (AR) drives copper accumulation in prostate cancer while inducing MTF1 to buffer copper toxicity. EP300‐mediated lactylation of MTF1 at K218 promotes its nuclear translocation and metallothionein expression, sequestering cytosolic copper and preventing mitochondrial cuproptosis.
Kai Li +21 more
wiley +1 more source

